STOCK TITAN

Cencora (COR) director Lon R. Greenberg granted 557 deferred stock units

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GREENBERG LON R reported acquisition or exercise transactions in this Form 4 filing.

Cencora, Inc. director Lon R. Greenberg reported an automatic equity award. He received an annual grant of 557 restricted stock units of common stock at no cash cost. The award vests 100% on the first anniversary of the grant date, with delivery of the shares deferred until 01/15/2029.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GREENBERG LON R

(Last) (First) (Middle)
1 WEST FIRST AVENUE

(Street)
CONSHOHOCKEN PA 19428

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/05/2026 A 557 A $359.28 18,408(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant. Receipt of shares deferred until 01/15/2029.
Remarks:
/s/ Elizabeth S. Campbell, attorney-in-fact for Lon R. Greenberg 03/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cencora (COR) director Lon R. Greenberg report?

Lon R. Greenberg reported receiving an annual equity grant of 557 restricted stock units of Cencora common stock. The units were granted for no cash consideration as part of director compensation and represent a stock-based award rather than an open-market share purchase.

Was the Cencora (COR) Form 4 transaction a stock purchase or sale?

The Form 4 shows an acquisition through a grant, not a market trade. Greenberg received 557 restricted stock units as a compensation award, so there was no open-market buying or selling of Cencora shares in this reported transaction.

How many Cencora (COR) shares does Lon R. Greenberg hold after this award?

After the reported grant, Lon R. Greenberg beneficially owns 18,408 shares of Cencora common stock. This total reflects his direct ownership following the addition of 557 restricted stock units reported in the latest Form 4 filing.

When do Lon R. Greenberg’s new Cencora (COR) restricted stock units vest?

The 557 restricted stock units granted to Lon R. Greenberg vest 100% on the first anniversary of the grant date. Although they vest then, actual receipt of the underlying Cencora shares is deferred until January 15, 2029, according to the footnote disclosure.

Did Lon R. Greenberg pay cash for the new Cencora (COR) shares?

No, the filing states the award was received for no consideration. The 557 restricted stock units represent a non-cash equity component of director compensation, rather than a purchase of Cencora shares in the open market or through an exercise transaction.

What does the deferral to January 15, 2029 mean for Cencora (COR) shares?

The deferral means Greenberg will not actually receive the Cencora shares underlying the 557 restricted stock units until January 15, 2029. Until that date, the award remains deferred, even though it is scheduled to vest in full one year after the grant date.
Cencora Inc.

NYSE:COR

View COR Stock Overview

COR Rankings

COR Latest News

COR Latest SEC Filings

COR Stock Data

68.60B
184.84M
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
CONSHOHOCKEN